Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with α-methylacyl CoA racemase

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 1, 2012, Pages 67-74

  Scarpelli, M ^a   Mazzucchelli, R ^a   Barbisan, F ^a   Santinelli, A ^a   Lopez Beltran, A ^b   Cheng, L ^c   Montironi, Rodolfo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrophy; High grade prostatic intraepithelial neoplasia; Prostate cancer; Prostate tumour overexpressed 1; PTOV1; methylacyl CoA racemase

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; MESSENGER RNA; PROSTATE TUMOR OVEREXPRESSED 1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; GENE OVEREXPRESSION; GLEASON SCORE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR OVEREXPRESSED 1; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; ATROPHY; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; GENE EXPRESSION; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM;

EID: 84861478112     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500109     Document Type: Article

References (21)

1. Benedit P, Paciucci R, Thomson TM, et al. PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks. Oncogene 2001; 20:1455-64. (Pubitemid 32291196)
2. Fernandez S, Mosquera JL, Alaña L, et al. PTOV1 is overexpressed in human high grade malignant tumors. Virchows Arch 2011; 458:323-30.
3. Morote J, Fernández S, Alaña L, et al. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy. Clin Cancer Res 2008; 14:2617-22.
4. Santamaría A, Castellanos E, Gómez V, et al. PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts. Mol Cell Biol 2005; 25:1900-11. (Pubitemid 40280153)
5. Santamaría A, Fernández PL, Farré X, Benedit P, Reventós J, Morote J, Paciucci R, Thomson TM. PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle. Am J Pathol 2003; 162:897-905. (Pubitemid 36237497)
6. Xu J, Stolk JA, Zhang X, Silva SJ, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 2000; 60: 1677-82. (Pubitemid 30183441)
7. Jiang Z, Wu CL, Woda BA, Dresser K, Xu J, Fanger GR, Yang XJ. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol 2002; 26:1169-74. (Pubitemid 34969186)
8. Ananthanarayanan V, Deaton RJ, Yang XJ, Pins MR, Gann PH. Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer. BMC Cancer 2006; 6:73.
9. Mazzucchelli R, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R. Immunohistochemical expression of prostate tumor overexpressed 1 in cystoprostatectomies with incidental and insignificant prostate cancer. Further evidence for field effect in prostatic carcinogenesis. Hum Pathol 2011; 42:1931-6.
10. Barbisan F, Mazzucchelli R, Santinelli A, Lopez-Beltran A, Cheng L, Scarpelli M, Montorsi F, Montironi R. Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomies. Eur Urol 2009; 56:105-12.
11. Mazzucchelli R, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R. Immunohistochemical expression of prostate stem cell antigen (PSCA) in cystoprostatectomies with incidental prostate cancer. Int J Immunopathol Pharmacol 2009; 22:755-62.
12. Montironi R, Mazzucchelli R, Barbisan F, Stramazzotti D, Santinelli A, Scarpelli M, Lopez-Beltran A. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer. Hum Pathol 2006; 37:1137-44. (Pubitemid 44286977)
13. Montironi R, Mazzucchelli R, Santinelli A, Scarpelli M, Lopez-Beltran A and Bostwick DG. Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens. Hum Pathol 2005; 36:646-54. (Pubitemid 40922571)
14. Morichetti D, Mazzucchelli R, Stramazzotti D, et al. Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. BJU Int 2010; 106:1072-80.
15. Santinelli A, Mazzucchelli R, Barbisan F, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R. alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer. Am J Clin Pathol 2007; 128:657-66.
16. Adley BP, Yang XJ. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review. Anal Quant Cytol Histol 2006; 28:1-13. (Pubitemid 43334515)
17. Beach R, Gown AM, De Peralta-Venturina MN, et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol 2002; 26:1588-96. (Pubitemid 35387221)
18. Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 2001; 25:1397-404. (Pubitemid 33022055)
19. Zhou M, Chinnaiyan AM, Kleer CG, Lucas PC, Rubin MA. Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol 2002; 26:926-31. (Pubitemid 34747646)
20. Paner GP, Luthringer DJ, Amin MB. Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies. Arch Pathol Lab Med 2008; 132:1388-96.
21. Wu X, Zayzafoon M, Zhang X, Hameed O. Is there a role for fatty acid synthase in the diagnosis of prostatic adenocarcinoma? A comparison with AMACR. Am J Clin Pathol 2011; 136:239-46.